Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Trizivir + tenofovir in antiretroviral-naive HIV-1 infected patients
2004-001646-32Phase 4Active
- Sponsor
- Daniel Podzamczer
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abacavir and tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1, sponsored by Daniel Podzamczer. Primary endpoint: Virologic suppression at 1 year. Started Oct 2004; status: active.
02
Drugs
abacavirtenofovir disoproxil fumarate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2004-001646-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001646-32.